Last Price
0.008
Today's Change
0.00 (0.00%)
Day's Change
0.007 - 0.008
Trading Volume
1,070,869
Overview
Market Cap
35 Million
Shares Outstanding
4 Billion
Avg Volume
7,196,375
Avg Price (50 Days)
0.01
Avg Price (200 Days)
0.01
PE Ratio
-0.80
EPS
-0.01
Earnings Announcement
25-Feb-2025
Previous Close
0.01
Open
0.01
Day's Range
0.007 - 0.008
Year Range
0.004 - 0.015
Trading Volume
1,525,200
Price Change Highlight
1 Day Change
0.00%
5 Day Change
0.00%
1 Month Change
-42.86%
3 Month Change
-11.11%
6 Month Change
100.00%
Ytd Change
-5.89%
1 Year Change
5.88%
3 Year Change
-78.46%
5 Year Change
-92.83%
10 Year Change
-89.75%
Max Change
-95.55%
News and Blogs
No result.
Company Profile
Sector: Healthcare - Healthcare
Industry: Medical Devices
Description:
OncoSil Medical Limited, a medical device company, focuses on the development and commercialization of localized radiation therapy for the treatment of pancreatic and distal cholangiocarcinoma in worldwide. Its lead product is OncoSil, a brachytherapy device indicated for the treatment of patients with locally advanced unresectable pancreatic cancer, in combination with gemcitabine-based chemotherapy. The company was formerly known as NeuroDiscovery Limited and changed its name to OncoSil Medical Limited in May 2013. OncoSil Medical Limited was incorporated in 2005 and is headquartered in North Sydney, Australia.
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Apps
Top Articles
1
CEO Morning Brief
Australia Faces Economic Pain From Trump Win, Treasurer Warns
2
CEO Morning Brief
#
Stock
Score
Daily Stocks
Stock
Last
Change
Volume
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
